Search





Search





10X Genomics Inc

TXG

Add to Watchlist

70.110USD

+1.520+2.22%

Close 09-14 16:00（ET）

9.14BMarket Cap

LossP/E TTM

10X Genomics Inc

70.110

+1.520+2.22%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Revenue Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Revenue Earnings Company Valuation Risk Assessment

TXG Cash Flow Statement

You can access the annual and quarterly cash flow statements of 10X Genomics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2018Q4

FY2018Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-4.15%16.97M

-23.96%26.12M

704.28%40.78M

99.69%43.21M

136.23%17.71M

318.45%34.35M

-126.20%-6.75M

185.52%21.64M

165.04%7.50M

-281.21%-15.72M

87.70%25.76M

-164.58%-25.30M

32.05%-11.53M

80.17%-4.13M

136.40%13.72M

63.52%-9.56M

-643.69%-16.96M

-409.60%-20.80M

104.46%5.80M

52.87%-26.22M

110.57%3.12M

-58.46%-4.08M

-2042.91%-130.18M

-482.96%-55.63M

---29.52M

---2.58M

113.14%6.70M

380.21%14.53M

---51.00M

---5.18M

Net income from continuing operations

-151.92%-17.93M

60.80%-13.47M

66.85%-16.25M

23.16%-27.47M

191.14%34.54M

42.69%-34.36M

-0.16%-49.03M

61.55%-35.75M

39.28%-37.90M

-18.13%-59.95M

-184.36%-48.95M

-121.85%-92.99M

3.17%-62.41M

-19.65%-50.75M

6.69%-17.21M

-144.10%-41.91M

-483.22%-64.46M

-267.18%-42.41M

95.56%-18.45M

73.92%-17.17M

72.48%-11.05M

45.37%-11.55M

-5725.25%-415.57M

-585.70%-65.85M

---40.17M

---21.14M

90.55%-7.13M

37.42%-9.60M

---75.52M

---15.35M

Operating gains losses

23.66%9.66M

0.29%9.96M

21.05%11.32M

22.68%11.00M

-12.89%7.82M

-14.77%9.93M

-44.27%9.35M

-4.35%8.96M

-29.51%8.97M

79.70%11.65M

157.28%16.78M

52.24%9.37M

95.78%12.73M

4.70%6.48M

12.80%6.52M

8.08%6.16M

32.95%6.50M

30.28%6.19M

47.55%5.78M

58.57%5.70M

47.57%4.89M

49.01%4.75M

37.72%3.92M

75.99%3.59M

--3.31M

--3.19M

219.66%2.84M

140.68%2.04M

--890.00K

--848.00K

Deferred tax

---1.43M

----

Other non-cash items

7.27%1.59M

406.09%1.76M

-7.02%1.64M

-17.75%1.52M

-25.53%1.49M

-120.95%-575.00K

-9.25%1.77M

-2.99%1.85M

-16.88%1.99M

20.14%2.74M

-9.78%1.95M

-12.17%1.91M

8.26%2.40M

16.12%2.28M

39.79%2.16M

37.37%2.17M

-3.57%2.22M

14.63%1.97M

-99.50%1.54M

22.88%1.58M

98.96%2.30M

-34.23%1.72M

1060237.93%307.50M

4842.31%1.28M

--1.16M

--2.61M

-96.85%29.00K

-78.33%26.00K

--921.00K

--120.00K

Change in working capital

92.44%-4.06M

-81.30%5.29M

1450.15%18.58M

144.54%31.77M

-1220.76%-53.69M

549.10%28.28M

-108.06%-1.38M

-19.65%12.99M

59.08%-4.07M

-5.65%-6.30M

188.22%17.07M

262.69%16.17M

-503.62%-9.93M

52.68%-5.96M

-93.70%-19.34M

76.49%-9.94M

112.32%2.46M

17.17%-12.59M

75.23%-9.99M

-400.77%-42.27M

-160.36%-19.98M

-351.28%-15.21M

-785.06%-40.32M

-146.41%-8.44M

---7.67M

--6.05M

-72.75%5.88M

115.98%18.19M

--21.59M

--8.42M

-Change in receivables

108.35%5.50M

-26.09%26.11M

422.70%14.10M

198.13%22.91M

-54109.84%-65.89M

50.22%35.33M

60.18%-4.37M

147.53%7.68M

101.25%122.00K

-10.51%23.52M

46.78%-10.97M

-119.87%-16.16M

-3383.84%-9.75M

201.09%26.28M

-202.14%-20.62M

62.09%-7.35M

118.17%297.00K

241.02%8.73M

55.08%-6.83M

-45.80%-19.39M

-120.12%-1.64M

-345.50%-6.19M

-110.37%-15.19M

-2401.04%-13.30M

--8.13M

--2.52M

19.68%-7.22M

132.13%578.00K

---8.99M

---1.80M

-Change in inventory

-57.29%3.00M

-66.47%2.70M

-41.97%5.58M

270.98%7.29M

235.19%7.03M

181.09%8.06M

26.33%9.62M

-265.97%-4.26M

-179.11%-5.20M

-2113.14%-9.94M

632.08%7.61M

129.65%2.57M

74.72%-1.86M

87.98%-449.00K

83.71%-1.43M

-21.39%-8.66M

-31.49%-7.37M

56.63%-3.74M

-84.79%-8.78M

-112.32%-7.13M

-133.28%-5.60M

-110.77%-8.61M

-142.01%-4.75M

-242.86%-3.36M

---2.40M

---4.09M

-14.12%-1.96M

-138.44%-980.00K

---1.72M

---411.00K

-Change in prepaid expenses

-74.82%1.21M

135.17%1.95M

-14.94%-2.98M

-13.24%1.38M

323.43%4.79M

-172.55%-5.53M

-313.39%-2.60M

204.66%1.59M

-46.90%1.13M

52.29%-2.03M

159.72%1.22M

-152.68%-1.52M

244.41%2.13M

-9.81%-4.25M

-1320.36%-2.04M

2027.33%2.89M

-386.96%-1.48M

-144.51%-3.87M

108.78%167.00K

90.95%-150.00K

122.28%514.00K

-363.56%-1.58M

-144.16%-1.90M

-4.87%-1.66M

---2.31M

--601.00K

-1086.08%-779.00K

-153.21%-1.58M

--79.00K

---624.00K

-Change in other current assets

-9864.00%-12.21M

-87.81%282.00K

-309.01%-1.60M

-152.65%-149.00K

105.32%125.00K

971.30%2.31M

297.42%766.00K

-98.41%283.00K

69.10%-2.35M

102.06%216.00K

-175.49%-388.00K

5907.77%17.78M

-18002.38%-7.60M

-6768.79%-10.47M

-26.26%514.00K

125.95%296.00K

-180.77%-42.00K

-4.85%157.00K

722.32%697.00K

-66.58%131.00K

102.96%52.00K

113.64%165.00K

62.67%-112.00K

-94.05%392.00K

---1.76M

---1.21M

81.73%-300.00K

1422.89%6.59M

---1.64M

---498.00K

-Change in other current liabilities

-1056.80%-1.45M

-96.18%27.00K

-54.05%1.47M

-96.56%91.00K

-103.31%-125.00K

-70.16%707.00K

-35.15%3.20M

-36.38%2.64M

107.41%3.78M

80.56%2.37M

214.81%4.93M

230.52%4.15M

14.67%1.82M

200.92%1.31M

611.76%1.57M

-740.24%-3.18M

1028.65%1.59M

113.67%436.00K

-155.04%-306.00K

-67.54%497.00K

-111.91%-171.00K

39.48%-3.19M

439.81%556.00K

-4.85%1.53M

--1.44M

---5.27M

-96.75%103.00K

53.24%1.61M

--3.17M

--1.05M

Cash from non-recurring investing activities

Cash from operating activities

-4.15%16.97M

-23.96%26.12M

704.28%40.78M

99.69%43.21M

136.23%17.71M

318.45%34.35M

-126.20%-6.75M

185.52%21.64M

165.04%7.50M

-281.21%-15.72M

87.70%25.76M

-164.58%-25.30M

32.05%-11.53M

80.17%-4.13M

136.40%13.72M

63.52%-9.56M

-643.69%-16.96M

-409.60%-20.80M

104.46%5.80M

52.87%-26.22M

110.57%3.12M

-58.46%-4.08M

-2042.91%-130.18M

-482.96%-55.63M

---29.52M

---2.58M

113.14%6.70M

380.21%14.53M

---51.00M

---5.18M

Investing cash flow

Net cash from continuing investing activities

0.63%1.59M

-15.64%1.60M

-34.57%1.78M

-82.33%687.00K

-59.31%1.58M

-34.95%1.89M

-21.28%2.72M

-74.81%3.89M

-84.71%3.88M

-44.91%2.91M

-91.32%3.45M

-57.79%15.44M

-6.84%25.36M

-81.23%5.28M

43.87%39.73M

80.81%36.57M

86.84%27.22M

-27.61%28.14M

24.04%27.62M

1444.05%20.23M

116.17%14.57M

381.06%38.87M

238.34%22.27M

-90.42%1.31M

--6.74M

--8.08M

132.63%6.58M

2109.69%13.68M

--2.83M

--619.00K

Capital expenditures

0.63%1.59M

-15.64%1.60M

-34.57%1.78M

-82.33%687.00K

-59.31%1.58M

-34.95%1.89M

-21.28%2.72M

-74.81%3.89M

-84.71%3.88M

-44.91%2.91M

-91.32%3.45M

-57.79%15.44M

-6.84%25.36M

-81.23%5.28M

43.87%39.73M

80.81%36.57M

86.84%27.22M

-27.61%28.14M

24.04%27.62M

1444.05%20.23M

116.17%14.57M

381.06%38.87M

238.34%22.27M

-90.42%1.31M

--6.74M

--8.08M

132.63%6.58M

2109.69%13.68M

--2.83M

--619.00K

Net cash flow from disposal of fixed assets

0.63%1.59M

-15.64%1.60M

-34.57%1.78M

-82.33%687.00K

-45.17%1.58M

-34.95%1.89M

-21.28%2.72M

-74.47%3.89M

-88.65%2.88M

-36.17%2.91M

-91.32%3.45M

-58.34%15.24M

-6.84%25.36M

-83.80%4.56M

43.87%39.73M

80.81%36.57M

86.84%27.22M

-27.61%28.14M

29.42%27.62M

3873.87%20.23M

116.17%14.57M

381.06%38.87M

225.49%21.34M

-96.28%509.00K

--6.74M

--8.08M

172.71%6.56M

2109.69%13.68M

--2.40M

--619.00K

Net cash flow from intangible asset transactions

----

--0.00

----

--0.00

-100.00%0.00

--1.00M

-100.00%0.00

--0.00

--200.00K

--0.00

--723.00K

----

-100.00%0.00

----

3608.00%927.00K

--801.00K

----

-94.12%25.00K

----

--425.00K

----

Net cash flow from business transactions

---6.10M

----

---652.00K

---8.62M

----

100.00%0.00

----

---2.50M

---1.50M

--0.00

100.00%0.00

--0.00

---5.45M

----

Net cash flow from investment products

-107.20%-46.00K

--286.00K

101.28%624.00K

85.24%502.00K

-95.96%639.00K

-100.00%0.00

-395.36%-48.88M

-98.67%271.00K

-24.26%15.82M

-89.19%13.54M

82.61%16.55M

273.69%20.34M

6883.77%20.89M

154.59%125.24M

--9.06M

--5.44M

---308.00K

---229.42M

----

Net cash flow from other investing activities

---6.60M

--0.00

---8.62M

----

Cash from non-current investing activities

Net cash flow from investing activities

-723.75%-7.74M

30.74%-1.31M

96.50%-1.80M

-143.26%-8.80M

-107.86%-939.00K

-117.80%-1.89M

-493.89%-51.59M

-173.84%-3.62M

367.75%11.95M

-91.14%10.63M

139.49%13.10M

115.02%4.90M

83.79%-4.46M

146.57%119.96M

-20.11%-33.17M

-61.32%-32.63M

-88.96%-27.53M

-481.19%-257.56M

-24.04%-27.62M

-1444.05%-20.23M

-116.17%-14.57M

-448.53%-44.32M

-238.34%-22.27M

90.42%-1.31M

---6.74M

---8.08M

-132.63%-6.58M

-2109.69%-13.68M

---2.83M

---619.00K

Financing cash flow

Cash flow from continuous financing activities

-14.37%3.02M

-2094.55%-8.42M

-50.37%2.24M

295.51%617.00K

-23.48%3.52M

-74.24%422.00K

-19.53%4.52M

-96.43%156.00K

-35.13%4.60M

147.98%1.64M

12.24%5.61M

114.52%4.37M

11.57%7.10M

-241.25%-3.41M

-43.83%5.00M

-69.49%2.04M

-60.72%6.36M

-31.30%2.42M

15.53%8.90M

-98.63%6.68M

101.13%16.19M

110.40%3.52M

796.12%7.71M

17.16%486.97M

--8.05M

---33.82M

-103.09%-1.11M

101028.47%415.64M

--35.88M

--411.00K

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

--0.00

---31.26M

--0.00

Net cash flow from common stock issuance/repurchase

----

100.00%0.00

----

57.95%-780.00K

17.62%483.05M

----

-203.17%-1.85M

89183.30%410.67M

--1.80M

---461.00K

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--0.00

--34.95M

--0.00

Proceeds from stock option exercised by employees

-14.37%3.02M

-35.31%273.00K

-50.37%2.24M

295.51%617.00K

-23.48%3.52M

-74.24%422.00K

-19.53%4.52M

-96.43%156.00K

-35.13%4.60M

-31.75%1.64M

12.24%5.61M

114.52%4.37M

11.57%7.10M

-69.33%2.40M

-43.83%5.00M

-69.49%2.04M

-60.72%6.36M

-8.42%7.83M

4.89%8.90M

70.44%6.68M

101.13%16.19M

160.31%8.55M

1034.76%8.49M

29.92%3.92M

--8.05M

--3.28M

185.78%748.00K

246.10%3.02M

---872.00K

--872.00K

Net cash flow from other financing activities

--0.00

---8.69M

--0.00

----

--0.00

100.00%0.00

--0.00

-7.49%-5.81M

--0.00

-7.58%-5.41M

100.00%0.00

--0.00

13.99%-5.03M

---2.00K

-100.00%0.00

--0.00

---5.85M

----

--1.95M

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-14.37%3.02M

-2094.55%-8.42M

-50.37%2.24M

295.51%617.00K

-23.48%3.52M

-74.24%422.00K

-19.53%4.52M

-96.43%156.00K

-35.13%4.60M

147.98%1.64M

12.24%5.61M

114.52%4.37M

11.57%7.10M

-241.25%-3.41M

-43.83%5.00M

-69.49%2.04M

-60.72%6.36M

-31.30%2.42M

15.53%8.90M

-98.63%6.68M

101.13%16.19M

110.40%3.52M

796.12%7.71M

17.16%486.97M

--8.05M

---33.82M

-103.09%-1.11M

101028.47%415.64M

--35.88M

--411.00K

Net cash flow

Beginning cash balance

30.03%490.29M

37.75%473.97M

8.68%432.71M

4.71%397.71M

5.98%377.06M

-4.24%344.07M

26.50%398.16M

14.80%379.82M

4.70%355.78M

58.03%359.28M

30.30%314.74M

17.41%330.85M

6.15%339.79M

-61.86%227.35M

-60.34%241.55M

-56.56%281.79M

-50.29%320.11M

-13.44%596.07M

-26.94%609.07M

60.69%648.71M

49.10%643.96M

44.52%688.64M

74.60%833.70M

561.33%403.69M

--431.90M

--476.49M

442.20%477.49M

-34.69%61.04M

--88.06M

--93.46M

Current period cash flow changes

-40.79%12.23M

-50.54%16.32M

176.27%41.26M

90.88%35.00M

-14.11%20.65M

1041.88%32.99M

-221.43%-54.09M

213.78%18.34M

368.91%24.04M

-103.12%-3.50M

413.77%44.55M

59.95%-16.11M

76.67%-8.94M

140.75%112.44M

-9.27%-14.20M

-1.51%-40.24M

-906.61%-38.32M

-517.54%-275.96M

91.04%-12.99M

-109.22%-39.64M

116.84%4.75M

-0.22%-44.69M

-14463.65%-145.05M

3.26%430.01M

---28.21M

---44.59M

94.46%-996.00K

7820.56%416.45M

---17.98M

---5.39M

Effect of exchange rate changes

-107.78%-28.00K

-164.04%-73.00K

115.99%43.00K

-121.15%-33.00K

12100.00%360.00K

337.50%114.00K

-449.35%-269.00K

283.53%156.00K

93.88%-3.00K

-300.00%-48.00K

-69.32%77.00K

0.00%-85.00K

74.48%-49.00K

233.33%24.00K

406.10%251.00K

-172.65%-85.00K

-3300.00%-192.00K

-109.33%-18.00K

74.29%-82.00K

657.14%117.00K

185.71%6.00K

266.38%193.00K

-3887.50%-319.00K

46.15%-21.00K

---7.00K

---116.00K

70.37%-8.00K

-1850.00%-39.00K

---27.00K

---2.00K

Ending cash balance

26.35%502.51M

30.03%490.29M

37.75%473.97M

8.68%432.71M

4.71%397.71M

5.98%377.06M

-4.24%344.07M

26.50%398.16M

14.80%379.82M

4.70%355.78M

58.03%359.28M

30.30%314.74M

17.41%330.85M

6.15%339.79M

-61.86%227.35M

-60.34%241.55M

-56.56%281.79M

-50.29%320.11M

-13.44%596.07M

-26.94%609.07M

60.69%648.71M

49.10%643.96M

44.52%688.64M

74.60%833.70M

--403.69M

--431.90M

579.85%476.49M

442.20%477.49M

--70.09M

--88.06M

Free cash flow

-4.61%15.39M

-24.45%24.52M

512.09%39.00M

139.56%42.53M

345.83%16.13M

274.18%32.46M

-142.42%-9.46M

143.57%17.75M

109.81%3.62M

-98.10%-18.64M

185.76%22.31M

11.70%-40.74M

16.52%-36.88M

80.78%-9.41M

-19.25%-26.01M

0.66%-46.14M

-285.94%-44.18M

-13.95%-48.94M

85.69%-21.81M

18.43%-46.44M

68.43%-11.45M

-303.07%-42.95M

-128201.68%-152.44M

-6814.50%-56.94M

---36.26M

---10.65M

100.22%119.00K

114.61%848.00K

---53.83M

---5.80M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did 10X Genomics Inc Generate?



10X Genomics Inc generated 136.05M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did 10X Genomics Inc's Operating Cash Flow Change Year Over Year?



10X Genomics Inc's operating cash flow increased by 1941.57% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does 10X Genomics Inc Spend on Capital Expenditures?



10X Genomics Inc spent 5.93M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has 10X Genomics Inc's Financing Cash Flow Changed?



10X Genomics Inc used 6.80M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TXG?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was 10X Genomics Inc’s free cash flow in the latest quarter?



Free cash flow was 130.12M reflecting a 2033.65% change from the previous year.